No changes in hemostasis after COVID-19–heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study

BACKGROUND: Several cases of unusual thrombotic events and thrombocytopenia were described after vaccination with recombinant adenoviral vectors encoding the spike protein antigen of SARS-CoV-2. OBJECTIVES: The objective of this study was to elucidate the impact of a COVID-19 heterologous vaccinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Butta, Nora V., Arias-Salgado, Elena G., Monzón Manzano, Elena, Acuña, Paula, Álvarez Román, María Teresa, Buño-Soto, Antonio, Ramos Ramos, Juan Carlos, Belda-Iniesta, Cristóbal, Frías, Jesús, Carcas, Antonio J., de Soto, Lucía Martínez, de Miguel Buckley, Rosa, Lora, David, García-Morales, María Teresa, Borobia, Alberto M., Arribas, José Ramón, Jiménez Yuste, Víctor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840220/
https://www.ncbi.nlm.nih.gov/pubmed/36685004
http://dx.doi.org/10.1016/j.rpth.2023.100049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840220/
https://www.ncbi.nlm.nih.gov/pubmed/36685004
http://dx.doi.org/10.1016/j.rpth.2023.100049

Ejemplares similares